NCT06245811View on ClinicalTrials.gov

Inflammation Markers in Hyperemesis Gravidarum

CompletedOBSERVATIONAL
Enrollment

215

Participants

Timeline

Start Date

January 20, 2022

Primary Completion Date

March 20, 2022

Study Completion Date

June 20, 2022

Conditions
Hyperemesis Gravidarum
Trial Locations (1)

Unknown

Yuzuncu Yil University, Faculty of Medicine, Van

Sponsors

Lead Sponsor

Izzet Celegen
All Listed Sponsors
lead

Izzet Celegen

OTHER

NCT06245811 - Inflammation Markers in Hyperemesis Gravidarum | Biotech Hunter | Biotech Hunter